Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma
DM Schuster, JR Votaw, PT Nieh, W Yu… - Journal of Nuclear …, 2007 - Soc Nuclear Med
Conventional imaging techniques have serious limitations in the detection, staging, and
restaging of prostate carcinoma. Anti-1-amino-3- 18 F-fluorocyclobutane-1-carboxylic acid (anti- …
restaging of prostate carcinoma. Anti-1-amino-3- 18 F-fluorocyclobutane-1-carboxylic acid (anti- …
Hyperspectral imaging and quantitative analysis for prostate cancer detection
…, A Osunkoya, V Master, PT Nieh… - … of biomedical optics, 2012 - spiedigitallibrary.org
Hyperspectral imaging (HSI) is an emerging modality for various medical applications. Its
spectroscopic data might be able to be used to noninvasively detect cancer. Quantitative …
spectroscopic data might be able to be used to noninvasively detect cancer. Quantitative …
Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography …
T Bach-Gansmo, C Nanni, PT Nieh, L Zanoni… - The Journal of …, 2017 - auajournals.org
Purpose : Sensitive detection of cancer foci in men experiencing biochemical recurrence
following initial treatment of prostate cancer is of great clinical significance with a possible …
following initial treatment of prostate cancer is of great clinical significance with a possible …
Anti-3-[18F]FACBC Positron Emission Tomography-Computerized Tomography and 111In-Capromab Pendetide Single Photon Emission Computerized …
DM Schuster, PT Nieh, AB Jani, R Amzat… - The Journal of …, 2014 - auajournals.org
Purpose : We prospectively evaluated the amino acid analogue positron emission tomography
radiotracer anti-3-[ 18 F]FACBC compared to ProstaScint® ( 111 In-capromab pendetide) …
radiotracer anti-3-[ 18 F]FACBC compared to ProstaScint® ( 111 In-capromab pendetide) …
Detection of Recurrent Prostate Carcinoma with anti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and 111In–Capromab Pendetide SPECT/CT
Purpose To compare the diagnostic performance of the synthetic amino acid analog
radiotracer anti-1-amino-3-fluorine 18-fluorocyclobutane-1-carboxylic acid (anti-3- 18 F-FACBC) …
radiotracer anti-1-amino-3-fluorine 18-fluorocyclobutane-1-carboxylic acid (anti-3- 18 F-FACBC) …
Recurrent prostate cancer detection with anti-3-[18F]FACBC PET/CT: comparison with CT
OA Odewole, FI Tade, PT Nieh, B Savir-Baruch… - European journal of …, 2016 - Springer
Purpose To compare the diagnostic performance of the synthetic amino acid analogue PET
radiotracer anti-3-[ 18 F]FACBC (fluciclovine) with that of CT in the detection of recurrent …
radiotracer anti-3-[ 18 F]FACBC (fluciclovine) with that of CT in the detection of recurrent …
[HTML][HTML] Absorbable hydrogel spacer use in prostate radiotherapy: a comprehensive review of phase 3 clinical trial published data
…, PJ Aliotta, CJ Skomra, LE Ponsky, PT Nieh… - Urology, 2018 - Elsevier
Objective To provide an update on SpaceOAR System, a Food and Drug Administration–approved
hydrogel indicated to create distance between the prostate and the rectum which has …
hydrogel indicated to create distance between the prostate and the rectum which has …
[HTML][HTML] Characterization of primary prostate carcinoma by anti-1-amino-2-[18F]-fluorocyclobutane-1-carboxylic acid (anti-3-[18F] FACBC) uptake
DM Schuster, PA Taleghani, PT Nieh… - American journal of …, 2013 - ncbi.nlm.nih.gov
Anti-1-amino-3-[18 F] fluorocyclobutane-1-carboxylic acid (anti-3-[18 F] FACBC) is a synthetic
amino acid positron emission tomography (PET) radiotracer with utility in the detection of …
amino acid positron emission tomography (PET) radiotracer with utility in the detection of …
Change in salvage radiotherapy management based on guidance with FACBC (fluciclovine) PET/CT in postprostatectomy recurrent prostate cancer
Purpose We explored the influence of FACBC (fluciclovine) PET/CT on the decision to offer
radiotherapy and radiotherapy treatment field recommendations in postprostatectomy …
radiotherapy and radiotherapy treatment field recommendations in postprostatectomy …
Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockade
…, P Venner, GP Haas, EJ Small, PT Nieh… - The Journal of …, 1997 - auajournals.org
Purpose : We determined whether decreases in prostate specific antigen (PSA) would occur
after withdrawal of double-blinded antiandrogen therapy with flutamide or bicalutamide for …
after withdrawal of double-blinded antiandrogen therapy with flutamide or bicalutamide for …